Tonix Pharmaceuticals Holding Corp.
TNXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001430306
In the last 90 days, Tonix Pharmaceuticals Holding Corp. insiders filed 3 open-market purchases and 0 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $119.6M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 11, 2026
- $75.2M
- Insider buysLast 90 days, $60.5K in total
- 3
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +23 vs. previous quarter
- 103
- 13F valueReported value at the end of Q2 2026
- $119.6M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $13.1M
- +29.8% year over year
- Net income, FY2025
- -$124.0M
- No comparable prior period
- Free cash flow, FY2025
- -$103.2M
- No comparable prior period
- Revenue, Q3 FY2026
- $17.2M
- +423.8% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $124.0M (946.2% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 3.32M
- Shares sold short
- Change
- +377.8K
- +12.9% vs. previous
- Days to cover
- 4.14
- At average daily volume
Superinvestors holding TNXP, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding TNXP at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Tonix Pharmaceuticals Holding Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2026 (view filing)8:00 AM ET | Nov 11 | 1 day | Lederman SethChief Executive Officer | PPurchaseCommon Stock, $0.001 par value | +5.00K | $4.06 | +$20.3K | +45.4%16.0K after | |
| Aug 31, 2026 (view filing)8:00 AM ET | Aug 27 | 4 days | Lederman SethChief Executive Officer | PPurchaseCommon Stock, $0.001 par value | +2.00K | $13.79 | +$27.6K | +22.2%11.0K after | |
| Aug 24, 2026 (view filing)8:00 AM ET | Aug 20 | 4 days | Bagger Richard HDirector | PPurchaseCommon Stock, par value $0.001 | +1.00K | $12.60 | +$12.6K | New position1.00K after | |
| Jun 15, 2026 (view filing) | Jun 12 | 3 days | Taylor Carolyn E.Director | PPurchaseCommon Stock, $0.001 par value | +1.42K | $10.55 | +$14.9K | +338.5%1.83K after | |
| Jun 9, 2026 (view filing) | Jun 9 | Same day | Lederman SethChief Executive Officer | PPurchaseCommon Stock, $0.001 par value | +5.00K | $11.79 | +$59.0K | +124.8%9.01K after | |
| Jun 9, 2026 (view filing) | Jun 8 | 1 day | Stillwell Richard NewcombDirector | PPurchaseCommon Stock, $0.001 par value | +5.00K | $11.65 | +$58.3K | New position5.00K after | |
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Lederman SethChief Executive Officer | PPurchaseCommon Stock, $0.001 par value | +5.00K | $12.62 | +$63.1K | +33.3%20.0K after | |
| Mar 18, 2026 (view filing) | Mar 18 | Same day | Lederman SethChief Executive Officer | PPurchaseCommon Stock, $0.001 par value | +15.0K | $14.89 | +$223.3K | +1,500,000.0%15.0K after | |
| Aug 21, 2025 (view filing) | Aug 21 | Same day | Taylor Carolyn E.Director | PPurchaseCommon Stock, par value $0.001 | +418 | $36.03 | +$15.1K | New position418 after | |
| Aug 20, 2025 (view filing) | Aug 20 | Same day | Treco JamesDirector | PPurchaseCommon Stock, par value $0.001 | +250 | $36.00 | +$9.00K | New position250 after |
Top 10 13F holders, Q2 2026
See all 103 holdersThe largest institutional positions in Tonix Pharmaceuticals Holding Corp. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,398,041 | $17.8M | 0.00% | +429,864+44.4% | Added |
| Point72 Asset Management, L.P. | 1,166,752 | $14.9M | 0.02% | +1,041,338+830.3% | Added |
| Millennium Management LLC | 966,932 | $12.3M | 0.01% | +747,259+340.2% | Added |
| AQR Capital Management LLC | 882,595 | $11.3M | 0.00% | +721,387+447.5% | Added |
| Vanguard Capital Management LLC | 691,895 | $8.83M | 0.00% | +173,245+33.4% | Added |
| Jones Hill Capital LP | 625,428 | $7.98M | 1.70% | +173,312+38.3% | Added |
| Geode Capital Management, LLC | 395,260 | $5.04M | 0.00% | +81,969+26.2% | Added |
| Ishara Investments LP | 338,250 | $4.32M | 3.23% | +338,250 | New |
| State Street Corp | 271,374 | $3.46M | 0.00% | +40,767+17.7% | Added |
| UBS Group AG | 231,682 | $2.96M | 0.00% | +40.0% | Added |
Holders of 5% or more of TNXP
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Tonix Pharmaceuticals Holding Corp..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 13G/A | 6.90%1.10M shares | −2.30 ppfrom 9.20% | Dec 31, 20252 filings | May 15, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 6.70%854.6K shares | −1.10 ppfrom 7.80% | Jul 17, 20253 filings | Jan 21, 2026 | SEC |
| Millennium Management LLC | 13G | 5.60%890.4K shares | New | Jun 15, 20261 filing | Jun 15, 2026 | SEC |
| AQR Capital Management LLC | 13G | 5.54%882.6K shares | New | Aug 13, 20261 filing | Aug 13, 2026 | SEC |